Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT

Dolsten Mikael received 22,862 Rocket Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 18, 2026 · Filed Jul 6, 2026

On Jun 18, 2026, Dolsten Mikael (Director) received 22,862 Rocket Pharmaceuticals, Inc. shares as an award, leaving 67,082 shares. Filed Jul 6, 2026 (Form 4).

Awarded
22,862 shares
Holding after
67,082 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockAward22,86267,082Direct

Source

View original at SEC

Related